Profil
Gregory P.
Licholai was the founder of Immunome, Inc. (2006) with the title of Director.
Dr. Licholai is currently the President of Elpidera LLC.
Former positions include Director-Ventures & Business Associates at Medtronic Neurological (2000-2002), Vice President-Medical Affairs at Amicus Therapeutics, Inc. (2004-2009), Partner at McKinsey & Co., Inc., Chief Medical & Innovation Officer at ICON plc, President-Rare Disease at Moderna, Inc., and President & Chief Scientific Officer at Castle Creek Biosciences, Inc. (2016-2018).
Education includes undergraduate degrees from Boston College and The Trustees of Columbia University in The City of New York, a doctorate from Yale School of Medicine, and an MBA from Harvard Business School.
Aktiva positioner av Gregory Licholai
| Företag | Position | Start |
|---|---|---|
Elpidera LLC | President | - |
Tidigare kända positioner av Gregory Licholai
| Företag | Position | Slut |
|---|---|---|
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | President | 2018-02-01 |
| AMICUS THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2009-10-02 |
Medtronic Neurological | Företagsledare/Principal | 2002-11-01 |
| MODERNA, INC. | Företagsledare/Principal | - |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Företagsledare/Principal | - |
Gregory Licholais utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 12 |
|---|---|
ICON plc
ICON plc Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services | Commercial Services |
Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Immunome, Inc.
Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Neurological | |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elpidera LLC | |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
















